182 related articles for article (PubMed ID: 36187165)
41. Extracts of
Song KH; Seo CS; Yang WK; Gu HO; Kim KJ; Kim SH
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33803357
[TBL] [Abstract][Full Text] [Related]
42. Rauwolfia vomitoria extract suppresses benign prostatic hyperplasia by reducing expression of androgen receptor and 5α-reductase in a rat model.
Fang T; Xue ZS; Li JX; Liu JK; Wu D; Li MQ; Song YT; Yun SF; Yan J
J Integr Med; 2021 May; 19(3):258-264. PubMed ID: 33341427
[TBL] [Abstract][Full Text] [Related]
43. Canagliflozin alleviates experimentally induced benign prostate hyperplasia in a rat model: exploring potential mechanisms involving mir-128b/EGFR/EGF and JAK2/STAT3 signaling pathways through in silico and in vivo investigations.
Elbaz EM; Darwish A; Gad AM; Abdel Rahman AAS; Safwat MH
Eur J Pharmacol; 2023 Oct; 957():175993. PubMed ID: 37598927
[TBL] [Abstract][Full Text] [Related]
44. Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats.
Al-Trad B; Aljabali A; Al Zoubi M; Shehab M; Omari S
Int J Nanomedicine; 2019; 14():3145-3154. PubMed ID: 31118628
[No Abstract] [Full Text] [Related]
45. Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis.
Jin BR; An HJ
Aging (Albany NY); 2020 Feb; 12(3):2142-2155. PubMed ID: 32018227
[TBL] [Abstract][Full Text] [Related]
46. Common salt aggravated pathology of testosterone-induced benign prostatic hyperplasia in adult male Wistar rat.
Bello II; Omigbodun A; Morhason-Bello I
BMC Urol; 2023 Dec; 23(1):207. PubMed ID: 38082261
[TBL] [Abstract][Full Text] [Related]
47. Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats.
Refaie MMM; Rifaai RA; Zenhom NM
Fundam Clin Pharmacol; 2018 Dec; 32(6):617-626. PubMed ID: 29862557
[TBL] [Abstract][Full Text] [Related]
48. 6-Paradol Alleviates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by Inhibiting AKT/mTOR Axis.
Binmahfouz LS; Almukadi H; Alamoudi AJ; El-Halawany AM; Abdallah HM; Algandaby MM; Mohamed GA; Ibrahim SRM; Alghamdi FA; Al-Shaeri M; Abdel-Naim AB
Plants (Basel); 2022 Oct; 11(19):. PubMed ID: 36235468
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
[TBL] [Abstract][Full Text] [Related]
50. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
[TBL] [Abstract][Full Text] [Related]
51. The effect of pomegranate fruit extract on testosterone-induced BPH in rats.
Ammar AE; Esmat A; Hassona MD; Tadros MG; Abdel-Naim AB; Guns ES
Prostate; 2015 May; 75(7):679-92. PubMed ID: 25620586
[TBL] [Abstract][Full Text] [Related]
52. Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase.
Youn DH; Park J; Kim HL; Jung Y; Kang J; Jeong MY; Sethi G; Seok Ahn K; Um JY
Oncotarget; 2017 Feb; 8(6):9500-9512. PubMed ID: 27880726
[TBL] [Abstract][Full Text] [Related]
53. The angiotensin converting enzyme inhibitor captopril attenuates testosterone-induced benign prostatic hyperplasia in rats; a mechanistic approach.
Mostafa F; Mantawy EM; Azab SS; El-Demerdash E
Eur J Pharmacol; 2019 Dec; 865():172729. PubMed ID: 31605676
[TBL] [Abstract][Full Text] [Related]
54. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
55. Purple rice extract inhibits testosterone-induced rat prostatic hyperplasia and growth of human prostate cancer cell line by reduction of androgen receptor activation.
Kiriya C; Yeewa R; Khanaree C; Chewonarin T
J Food Biochem; 2019 Sep; 43(9):e12987. PubMed ID: 31489669
[TBL] [Abstract][Full Text] [Related]
56. Bawu decoction () ameliorates benign prostatic hyperplasia in rats.
Eom JH; Cheon SY; Chung KS; Kim MD; An HJ
Chin J Integr Med; 2017 Aug; 23(8):611-616. PubMed ID: 27838873
[TBL] [Abstract][Full Text] [Related]
57. SH-PRO extract alleviates benign prostatic hyperplasia via ROS-mediated activation of PARP/caspase 3 and inhibition of FOXO3a/AR/PSA signaling in vitro and in vivo.
Park JE; Shin WC; Lee HJ; Yoon D; Sim DY; Ahn CH; Park SY; Shim BS; Park SJ; Kim KS; Park GD; Kim SH; Lee DY
Phytother Res; 2023 Feb; 37(2):452-463. PubMed ID: 36122906
[TBL] [Abstract][Full Text] [Related]
58. Biochemical and histomorphological changes in testosterone propionate-induced benign prostatic hyperplasia in male Wistar rats treated with ketogenic diet.
Kayode OT; Owolabi AV; Kayode AAA
Biomed Pharmacother; 2020 Dec; 132():110863. PubMed ID: 33113424
[TBL] [Abstract][Full Text] [Related]
59. Iodine prevents the increase of testosterone-induced oxidative stress in a model of rat prostatic hyperplasia.
Quintero-García M; Delgado-González E; Sánchez-Tusie A; Vázquez M; Aceves C; Anguiano B
Free Radic Biol Med; 2018 Feb; 115():298-308. PubMed ID: 29248723
[TBL] [Abstract][Full Text] [Related]
60. Inhibitory Effect of Artemisinin on Testosterone Propionate Induced Benign Prostatic Hyperplasia.
Solanki A; Patel S; Solanki N; Shah U
Curr Drug Discov Technol; 2021; 18(4):518-524. PubMed ID: 32532194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]